# Probiotic (VSL #3) for Gulf War Illness

> **NCT02011542** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Utah** · enrollment: 29 (actual)

## Conditions studied

- Gulf War Illness

## Interventions

- **DRUG:** VSL#3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02011542
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Original study product (VSL #3) became unavailable; change in study Collaborator and product
- **Last updated:** 2018-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011542, "Probiotic (VSL #3) for Gulf War Illness". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02011542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*